In clinical studies, Vyvanse significantly improved core ADHD symptoms: attention (e.g., focus, following instructions) and behavior (e.g., hyperactivity, impulsivity )
Active Ingredient: lisdexamfetamine dimesylate
Inactive Ingredients: microcrystalline cellulose, croscarmellose
sodium, and magnesium stearate. The capsule shells contain gelatin,
titanium dioxide, and one or more of the following: D&C Red #28, D&C
Yellow #10, FD&C Blue #1, FD&C Green #3, and FD&C Red #40.
...........................................................................................................
Some Benefits for your child
When your child’s ADHD symptoms are controlled consistently throughout the day, others can see those talents, too. Some of the benefits of Vyvanse, as shown in clinical studies, are: Vyvanse provided consistent ADHD symptom control for up to 12 hours. One capsule in the morning has been shown to provide consistent ADHD symptom control throughout the day, even at 6 pm.
Vyvanse controlled core ADHD symptoms
Vyvanse significantly improved core ADHD symptoms: attention (e.g., focus, following instructions) and behavior (e.g., hyperactivity, impulsivity).
Learn more about Vyvanse for kids
Read the FDA document on Vyvanse
Vyvanse provided overall improvement
In an open-label clinical study Vyvanse provided overall improvement in 95% of children taking Vyvanse for 12 months. Read stories about patients currently taking Vyvanse for a closer look at how Vyvanse is helping other children achieve success.
...........................................................................................................
Benefits for Adults
Vyvanse Significantly Improved ADHD Symptoms
The phase III pivotal trial that led to the FDA approval of VYVANSE to treat adults with ADHD was a double-blind, placebo-controlled, four-week study with dose escalations in 414 adults aged 18 to 55 years. In this study, adults with ADHD experienced significant improvements in ADHD symptom control within one week of treatment with once-daily VYVANSE.1
Treatment with VYVANSE at all doses studied (30 mg, 50 mg, 70 mg) was significantly more effective than placebo, providing a reduction in ADHD Rating Scale (ADHD-RS-IV) scores ranging from 16.2 to 18.6 points at endpoint.1 The ADHD-RS-IV is a standardized test for assessing symptoms of ADHD and for assessing their response to treatment.5,6 This scale, which contains 18 items, is based on the ADHD diagnostic criteria as defined in the APA’s Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision®, a publication of the American Psychiatric Association.7
Learn more about Vyvanse for adults and read the press release
Investigators also measured the efficacy of VYVANSE with the Clinical Global Impressions-Improvement (CGI-I) scale and found that the percentage of subjects taking VYVANSE that rated improved ranged from 57 to 61 percent across all doses and was significantly greater than placebo.1 The CGI-I scale is a standard assessment used to rate the severity of a patient’s illness and improvement over time.8
The most commonly reported adverse events in this study were decreased appetite, difficulty falling asleep, and dry mouth.
...........................................................................................................
Important Safety Information
Tell your doctor about any heart conditions, including structural abnormalities that you or your child or a family member may have. Inform the doctor immediately if you or your child develops symptoms that suggest heart problems such as chest pain or fainting.
Read the FDA document on Vyvanse
Vyvanse should not be take if you or your child has advanced disease of the blood vessels; symptomatic heart disease; moderate to severe high blood pressure; overactive thyroid gland; known allergy or unusual reactions to drugs called symphathomimetic amines; seizures; glaucoma; a history of problems with alcohol or drugs; agitated states; taken a monoamine oxidase inhibitor within the last 14 days.
For Health Professionals / Prescribing Information / Medication Guide
Tell the doctor before taking Vyvanse if you or your child is being treated or has symptoms of depression ( sadness, worthlessness or hopelessness ) or bipolar disorder; has abnormal thoughts or visions; hears abnormal sounds, or has been diagnosed with psychosis; has had seizures or abnormal EEGs; has or has had high blood pressure; exhibits aggressive behavior or hostility. Tell the doctor immediately if you or your child develops any of these conditions or symptoms while taking Vyvanse.
Abuse of amphetamines may lead to dependence. Misuse of Amphetamines may cause sudden death and serious cardiovascular adverse events. These events have also been reported rarely with amphetamine use.
Vyvanse was generally well tolerated in clinical studies. The most common side effects reported in studies of Vyvanse were: children - decreased appetite, difficulty falling asleep, stomach ache and irritability; adult decreased appetite, difficulty falling asleep and dry mouth.
Aggression, new abnormal thoughts / behaviors, mania, growth suppression, worsening of motion or verbal tics and Tourette's syndrome have been associated with use of drugs of this type. Tell the doctor if you or your child has blurred vision while taking Vyvanse.
